Programming errors contribute to death from patient-controlled analgesia: Case report and estimate of probability

Canadian Journal of Anesthesia

Volumn 50, Issue 4, 2003, Pages 328-332

  Vicente, Kim J ^a,b,c   Kada Bekhaled, Karima ^b   Hillel, Gillian ^b,c   Cassano, Andrea ^b   Orser, Beverly A ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; MORPHINE SULFATE;

ADULT; ANESTHESIST; ARTICLE; AUTOPSY; BLOOD SAMPLING; BOLUS INJECTION; CASE REPORT; CAUSE OF DEATH; CESAREAN SECTION; COMPUTER PROGRAM; DATA BASE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG SAFETY; EQUIPMENT DESIGN; EVIDENCE BASED MEDICINE; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; IATROGENIC DISEASE; INFUSION PUMP; NURSE; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; PROBABILITY; PRURITUS; SAFETY; STATISTICAL ANALYSIS;

EID: 0038805213     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03021027     Document Type: Article

References (25)

1. Ferrante FM, Ostheimer GW, Covino BG. Patient-Controlled Analgesia. Boston: Blackwell Scientific; 1990.
2. Classen DC, Pesotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991; 266: 2847-51.
3. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implication for prevention. JAMA 1995: 274: 29-34.
4. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. JAMA 1997; 277: 307-11.
5. Baxter AD. Respiratory depression with patient-controlled analgesia (Editorial). Can J Anaesth 1994; 41: 87-90.
6. Doyle DJ, Vicente KJ. Patient-controlled analgesia (Letter). CMAJ 2001; 164: 620.
7. Doyle DJ, Vicente KJ. Electrical short circuit as a possible cause of death in patients on PCA machines: report on an opiate overdose and a possible preventive remedy (Letter). Anesthesiology 2001; 94: 940.
8. Emergency Care Research Institute. Abbott PCA Plus II patient-controlled analgesic pumps prone to misprogramming resulting in narcotic overinfusions. Health Devices 1997; 26: 389-91.
9. Etches RC. Respiratory depression associated patient-controlled analgesia: a review of eight cases. Can J Anaesth 1994; 41: 125-32.
10. Geller RJ. Meperidine in patient-controlled analgesia: a near-fatal mishap. Anesth Analg 1993; 76: 655-7.
11. Grey TC, Sweeney ES. Patient-controlled analgesia (Letter). JAMA 1988; 259: 2240.
12. Grover ER, Heath ML. Patient-controlled analgesia. A serious incident. Anaesthesia 1992; 47: 402-4.
13. Institute for Safe Medication Practices. Evidence builds: lack of focus on human factors allows error-prone devices. ISMP Medication Safety Alert 1999; 4: 1-2.
14. Kwan A. Overdose of morphine during PCA (Letter). Anaesthesia 1995; 50: 919.
15. Looi-Lyons LC, Ching FF, Chan VW, McQuestion M. Respiratory depression: an adverse outcome during patient controlled analgesia therapy. J Clin Anaesth 1996; 8: 151-6.
16. Notcutt WG, Knowles P, Kaldas R. Overdose of opioid from patient-controlled analgesia pumps. Br J Anaesth 1992; 69: 95-7.
17. Simes D, Power L, Priestly G. Respiratory arrest with patient-controlled analgesia (Letter). Anaesth Intensive Care 1995; 23: 119-20.
18. Weinger MB, Pantiskas C, Wiklund ME, Carstensen P. Incorporating human factors into the design of medical devices (Letter). JAMA 1998; 280: 1484.
19. White PF. Mishaps with patient-controlled analgesia. Anesthesiology 1987; 66: 81-3.
20. Lin L, Vicente KJ, Doyle DJ. Patient safety, potential adverse drug events, and medical device design: a human factors engineering approach. J Biomed Inform 2001; 34: 274-84. (www.idealibrary.com/links/doi/10.1006/jbin.2001.1028/pdf, February 19, 2003).
21. Cullen DJ, Bates DW, Small SD, Cooper JB, Nemeskal AR, Leape LL. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv 1995; 21: 541-8.
22. Gardner S, Flack M. Designing a medical device surveillance network report to Congress. 1999. (www.fda.gov/cdrh/postsurv/medsun.html, February 19, 2002).
23. Jha AK, Kuperman GJ, Teich JM, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998; 5: 305-14.
24. McLeskey CH. Patient-controlled analgesia (Letter). CMAJ 2001; 164: 620-1.
25. Joint Commission on Accreditation of Healthcare Organisations. Sentinel events: approaches to error reduction and prevention. Jt Comm J Qual Improv 1998; 24: 175-86.